Mphi awarded in Poland

26 April 2010 - Corporate -

The new Mphi device for MLS® Laser Therapy has been awarded as the best new product at the Rehmed-Expo 2010 fair in Kielce.

Right at the first official presentation, the features of Mphi are fully appreciated: a modern design developed with attention to details, an innovative management software which allows new and more precise treatment modalities, a colored graphic interface which shows the anatomy emphasizing the treatment areas, all included in a light, easy-to-handle device, portable on shoulder belt, working with long autonomy battery.

Today the therapeutic qualities of the MLS® pulse are easily available in any situation.

 

You might also be interested in ...

See all articles

M-Hi All Terrain
News - 12/03/2025
M-Hi All Terrain redefines the standards of MLS® Laser Therapy, combining portability, resistance and operational autonomy to offer effective treatments anywhere.
2024 ASAlaser activities
News - 11/12/2024
Whether it’s by taking part in Congresses and Fairs or organising on-site courses or webinars, once again in 2024 ASA has proved to be highly proactive in both the human and veterinary fields.
El.En. e ASA unite nello sviluppo tecnologico
News - 09/12/2024
Research and Development are the pillars on which all the companies of the El.En. Group base their growth: technological innovation, continuous training and know-how sharing are the key words that...
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.